Related Experiment Video
Updated: Jan 31, 2026

Polarization and Characterization of M1 and M2 Human Monocyte-Derived Macrophages on Implant Surfaces
Published on: December 6, 2024
PRMT1-rich exosomes derived from M2 macrophages as novel therapeutics for enhancing fracture healing
Haifeng Hong1, Cuiyun Zhou2, Haibing Wang1
1Department of Orthopedics, Fuzhou First General Hospital Affiliated with Fujian Medical University, Fuzhou, Fujian 350000, China.
Purpose:
sM2 macrophage-derived exosomes (M2-Exo) have emerged as promising mediators of bone repair due to their anti-inflammatory and pro-regenerative properties. However, the molecular mechanisms underlying the interaction between M2-Exo and bone marrow mesenchymal stem cells (BMSCs) are awaiting clarification. Our previous study found that protein arginine methyltransferase 1 (PRMT1) in fracture-derived exosomes promotes bone healing. This study aimed to determine whether PRMT1-containing M2-Exo exerts an osteoprotective effect during fracture healing and elucidate its underlying mechanisms.
Methods:
Following knockdown of PRMT1 in M2-Exo and then treating BMSCs, osteogenic differentiation ability of BMSCs was evaluated by qRT-PCR, western blot, Alizarin Red S, and Alkaline phosphatase (ALP). Immunoprecipitation was employed to clarify regulatory effect of PRMT1 on Src-associated in mitosis 68 kDa (Sam68) and its asymmetric dimethylarginine (ADMA) modification.
Results:
PRMT1 was overexpressed in M2-Exo extracted from serum samples of fracture rats. M2-Exo delivered PRMT1 to BMSCs. PRMT1 knockdown in M2-Exo impaired osteogenic differentiation, as evidenced by suppressing mineral deposition and ALP activity (42.3 % and 60.8 % reduction vs. sh-NC; p < 0.01), with a decrease in expression of Bone Morphogenetic Protein 2 (BMP2) and RUNX Family Transcription Factor 2 (RUNX2) (74.9 % and 61.8 % decline vs. sh-NC; p < 0.01). PRMT1 interacted with Sam68, and its knockdown reduced ADMA modification and Sam68 protein expression. Sam68 overexpression partially rescued the osteogenic defects caused by PRMT1 knockdown, with increased mineralization level and ALP (44.3 % and 87.6 % increase vs. M2-Exo-sh-PRMT1 + oe-NC; p < 0.05), along with elevated BMP2 and RUNX2 expression (79.5 % and 98.8 % increase vs. M2-Exo-sh-PRMT1 + oe-NC; p < 0.01).
Conclusion:
PRMT1 released by M2-Exo is delivered to BMSCs, which enhances the osteogenic differentiation by catalyzing Sam68 ADMA. These findings provide a mechanistic and preclinical rationale for the potential use of M2-Exo to improve bone healing.
Insights
Macrophage-derived exosomes (M2-Exo) deliver protein arginine methyltransferase 1 (PRMT1) to bone marrow mesenchymal stem cells (BMSCs), enhancing bone healing. PRMT1 promotes osteogenic differentiation by modifying Sam68, offering a therapeutic strategy for fracture repair.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Cell Biology
Background:
- Macrophage-derived exosomes (M2-Exo) show potential in bone repair due to anti-inflammatory and regenerative properties.
- The precise molecular mechanisms of M2-Exo interaction with bone marrow mesenchymal stem cells (BMSCs) require further investigation.
- Previous research identified protein arginine methyltransferase 1 (PRMT1) in exosomes as a promoter of bone healing.
Purpose of the Study:
- To investigate the osteoprotective effect of PRMT1-containing M2-Exo during fracture healing.
- To elucidate the underlying molecular mechanisms of M2-Exo's action on BMSCs.
Main Methods:
- PRMT1 was knocked down in M2-Exo, which were then used to treat BMSCs.
- Osteogenic differentiation was assessed using qRT-PCR, western blot, Alizarin Red S, and Alkaline phosphatase (ALP) assays.
- Immunoprecipitation was used to study the interaction between PRMT1, Sam68, and its ADMA modification.
Main Results:
- PRMT1 delivered by M2-Exo enhanced BMSC osteogenic differentiation, evidenced by increased mineralization and ALP activity.
- Knockdown of PRMT1 in M2-Exo suppressed osteogenic differentiation and reduced BMP2 and RUNX2 expression.
- PRMT1 interacted with Sam68, and this interaction was crucial for ADMA modification and osteogenic gene expression; Sam68 overexpression partially rescued PRMT1 knockdown-induced defects.
Conclusions:
- M2-Exo-derived PRMT1 enhances BMSC osteogenic differentiation by catalyzing Sam68 ADMA modification.
- These findings support the potential of M2-Exo as a therapeutic agent for improving bone healing.
- The study provides a mechanistic understanding of M2-Exo's role in fracture repair.
More Related Videos
09:20Differentiation of Monocytes into Phenotypically Distinct Macrophages After Treatment with Human Cord Blood Stem Cell CB-SC-Derived Exosomes
Published on: November 12, 2020
05:53The Generation of Closed Femoral Fractures in Mice: A Model to Study Bone Healing
Published on: August 16, 2018
Related Concept Videos
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Fractures: Bone Repair
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
Therapeutic Index
Self-Evaluation: Self-Enhancement and Self-Verification
Bioavailability Enhancement: Drug Solubility Enhancement
Therapeutic Communication
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...